Iyengar Yoga for Adolescents and Young Adults With Irritable Bowel Syndrome

被引:58
作者
Evans, Subhadra [1 ]
Lung, Kirsten C. [1 ]
Seidman, Laura C. [1 ]
Sternlieb, Beth [1 ]
Zeltzer, Lonnie K. [1 ]
Tsao, Jennie C. I. [1 ]
机构
[1] Univ Calif Los Angeles, Pediat Pain Program, Los Angeles, CA 90024 USA
关键词
adolescents; irritable bowel syndrome; yoga; young adults; QUALITY-OF-LIFE; FUNCTIONAL ABDOMINAL-PAIN; CLINICAL-TRIALS; INVENTORY; SYMPTOMS; CHILDREN; ANXIETY;
D O I
10.1097/MPG.0000000000000366
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: Irritable bowel syndrome (IBS) is a chronic, disabling condition that greatly compromises patient functioning. The aim of this study was to assess the impact of a 6-week twice per week Iyengar yoga (IY) program on IBS symptoms in adolescents and young adults (YA) with IBS compared with a usual-care waitlist control group. Methods: Assessments of symptoms, global improvement, pain, health-related quality of life, psychological distress, functional disability, fatigue, and sleep were collected pre- and posttreatment. Weekly ratings of pain, IBS symptoms, and global improvement were also recorded until 2-month follow-up. A total of 51 participants completed the intervention (yoga = 29; usual-care waitlist = 22). Results: Baseline attrition was 24%. On average, the yoga group attended 75% of classes. Analyses were divided by age group. Relative to controls, adolescents (14-17 years) assigned to yoga reported significantly improved physical functioning, whereas YA (18-26 years) assigned to yoga reported significantly improved IBS symptoms, global improvement, disability, psychological distress, sleep quality, and fatigue. Although abdominal pain intensity was statistically unchanged, 44% of adolescents and 46% of YA reported a minimally clinically significant reduction in pain following yoga, and one-third of YA reported clinically significant levels of global symptom improvement. Analysis of the uncontrolled effects and maintenance of treatment effects for adolescents revealed global improvement immediately post-yoga that was not maintained at follow-up. For YA, global improvement, worst pain, constipation, and nausea were significantly improved postyoga, but only global improvement, worst pain, and nausea maintained at the 2-month follow-up. Conclusions: The findings suggest that a brief IY intervention is a feasible and safe adjunctive treatment for young people with IBS, leading to benefits in a number of IBS-specific and general functioning domains for YA. The age-specific results suggest that yoga interventions may be most fruitful when developmentally tailored.
引用
收藏
页码:244 / 253
页数:10
相关论文
共 33 条
  • [1] Barnes Patricia M, 2008, Natl Health Stat Report, P1
  • [2] 2 CONTROLLED EVALUATIONS OF MULTICOMPONENT PSYCHOLOGICAL TREATMENT OF IRRITABLE-BOWEL-SYNDROME
    BLANCHARD, EB
    SCHWARZ, SP
    SULS, JM
    GERARDI, MA
    SCHARFF, L
    GREENE, B
    TAYLOR, AE
    BERREMAN, C
    MALAMOOD, HS
    [J]. BEHAVIOUR RESEARCH AND THERAPY, 1992, 30 (02) : 175 - 189
  • [3] A pilot study of yoga treatment in children with functional abdominal pain and irritable bowel syndrome
    Brands, Marion M. M. G.
    Purperhart, Helen
    Deckers-Kocken, Judith M.
    [J]. COMPLEMENTARY THERAPIES IN MEDICINE, 2011, 19 (03) : 109 - 114
  • [4] THE PITTSBURGH SLEEP QUALITY INDEX - A NEW INSTRUMENT FOR PSYCHIATRIC PRACTICE AND RESEARCH
    BUYSSE, DJ
    REYNOLDS, CF
    MONK, TH
    BERMAN, SR
    KUPFER, DJ
    [J]. PSYCHIATRY RESEARCH, 1989, 28 (02) : 193 - 213
  • [5] Abdominal pain impacts quality of life in women with irritable bowel syndrome
    Cain, KC
    Headstrom, P
    Jarrett, ME
    Motzer, SA
    Park, H
    Burr, RL
    Surawicz, CM
    Heitkemper, MM
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (01) : 124 - 132
  • [6] A comparative review of generic quality-of-life instruments
    Coons, SJ
    Rao, S
    Keininger, DL
    Hays, RD
    [J]. PHARMACOECONOMICS, 2000, 17 (01) : 13 - 35
  • [7] Derogatis LR, 2001, BRIEF SYMPTOM INVENT, V18
  • [8] Core outcome measures for chronic pain clinical trials: IMMPACT recommendations
    Dworkin, RH
    Turk, DC
    Farrar, JT
    Haythornthwaite, JA
    Jensen, MP
    Katz, NP
    Kerns, RD
    Stucki, G
    Allen, RR
    Bellamy, N
    Carr, DB
    Chandler, J
    Cowan, P
    Dionne, R
    Galer, BS
    Hertz, S
    Jadad, AR
    Kramer, LD
    Manning, DC
    Martin, S
    McCormick, CG
    McDermott, MP
    McGrath, P
    Quessy, S
    Rappaport, BA
    Robbins, W
    Robinson, JP
    Rothman, M
    Royal, MA
    Simon, L
    Stauffer, JW
    Stein, W
    Tollett, J
    Wernicke, J
    Witter, J
    [J]. PAIN, 2005, 113 (1-2) : 9 - 19
  • [9] Evans S, 2008, INT J DISABIL HUM DE, V7, P25
  • [10] Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
    Farrar, JT
    Young, JP
    LaMoreaux, L
    Werth, JL
    Poole, RM
    [J]. PAIN, 2001, 94 (02) : 149 - 158